Two liquid chromatographic methods were developed and validated. Simple and sensitive thin-layer chromatography (TLC)-densitometric and high-performance liquid chromatographic (HPLC) methods were used for the simultaneous determination of flumethasone pivalate (FP), flumethasone pivalate related substance and impurity, flumethasone (FL), and clioquinol (CL). The proposed TLC-densitometric method has been developed using silica gel plates 60 F 254 as a stationary phase with benzene-hexane-acetoneformic acid (5:4:2:0.13, by volume) as a developing system followed by densitometric measurements at 235 nm. The studied components were quantified in the range of 0.3-4, 0.3-3, and 1.5-5 μg band −1 , respectively. For HPLC method, chromatographic separation was achieved within 11 min with the required peak symmetry, accuracy, and precision on ODS column using acetonitrile-water (70:30, v/v) as the mobile phase at a flow rate of 1 mL min −1 with ultraviolet (UV) detection at 235 nm. The calibration plots were linear over the concentration range of 5-50, 2-35, and 10-70 mg mL −1 , respectively. The proposed methods were validated as per International Conference on Harmonization (ICH) guidelines; accuracy, precision, and repeatability were found to be within the acceptable limits.
Introduction
Flumethasone pivalate (FP) is a corticosteroid used topically for its glucocorticoid activity in the treatment of various skin disorders; it produces dramatic suppression of skin diseases in which inflammation is a prominent feature [1] . Clioquinol (CL) is a halogenated hydroxyquinoline with antibacterial and antifungal activity [1] .
The two drugs are coformulated in ear drops for the treatment of otitis externa [1] . Flumethasone (FL) is the potential impurity and related substance of flumethasone pivalate [2] . FP was determined by several methods either in raw material or in pharmaceutical formulations including spectrophotometric [2] , colorimetric [3] , electrochemical [4, 5] , and high-performance liquid chromatography (HPLC) [6] methods.
CL was determined by spectrophotometric [7] , fluorimetric [8] , electrochemical [9] , gas chromatography (GC) [10] , and HPLC [9, 11, 12] methods.
As per survey in literature, no reported methods were found for the simultaneous determination of FP and CL either in their binary mixtures or in the presence of FL. The aims of this work were to: -develop validated chromatographic methods for the simultaneous determination of FP and CL in their binary mixture; -adopt the proposed methods to the analysis of the available dosage forms in order to solve the problems encountered in quality control analysis of the studied drugs; -determine the lowest concentrations of FL in FP samples.
Experimental

Instruments
CAMAG TLC Scanner 3 S/N 130319 with winCATS software
The following requirements were taken into consideration: -Source of radiation: deuterium lamp -Scan mode: absorbance mode -Slit dimension: 3 mm × 0.45 mm SIL G/UV 254 (Macherey-Nagel, Germany) 20 × 20 cm with 0.1-mm thickness 5. Sonix TV ss-series ultrasonicator (USA) 6. Shimadzu class-LC 10 AD liquid chromatograph supplied with an ultraviolet-visible (UV-vis) spectrophotometer detector, a degasser (DGU-3A), and a data processor (C-R4A), all from Shimadzu, Kyoto, Japan. The analytical column was a Phenomenex C18-ODS (Shimadzu, Kyoto, Japan), 25 cm × 4.6 mm I.D., 5 μm particle size protected by a C18 guard column.
Samples
Pure Samples
Both FP and CL were kindly supplied by Amoun Pharmaceutical Company, and their purities were found to be 99.65% and 99.73%, respectively, according to the manufacturer certificate. FL was supplied by Sigma-Aldrich Chemie GmbH, Germany, and its purity was found to be 99.35% according to the company certificate.
Market Samples
Viotic ® batch No. 124225 and Otocort ® batch No. 0650910 ear drops: each 1 mL of both of them claimed to contain 0.2 mg of FP and 10 mg of CL, manufactured by Amoun Pharmaceutical Company and Hi Pharm Company, respectively, and was obtained from local market.
Chemicals and Solvents
Benzene, acetone, hexane, and formic acid were of analytical grade (El-Nasr Pharmaceutical Chemicals Co., Abu-Zabaal, Cairo, Egypt). Acetonitrile was of HPLC grade (Sigma-Aldrich Chemie GmbH, Germany). Deionized water was from SEDICO Pharmaceuticals Co., Egypt.
Solutions
Stock standard solutions (1 mg mL −1 ) of FP, FL, and CL were prepared by separately weighing 100 mg of each of them into 100-mL volumetric flasks, dissolved in and diluted to the volume with methanol.
Working standard solutions of FP, FL, and CL (0.1 mg mL −1 ) were prepared by accurately diluting 10 mL from the corresponding stock solutions (1 mg mL −1 ) into 100-mL volumetric flask with methanol.
Sample Solutions
Five milliliters of each of Viotic ® and Otocort ® ear drops were separately transferred into 50-mL volumetric flasks, sonicated in 25 mL methanol for 5 min, and the volume was then completed to the mark with methanol in order to prepare the stock solution (1 mg mL −1 ) of CL, from which 10 mL were transferred to a 100-mL volumetric flask and completed to volume with methanol to prepare the working solution (0.1 mg mL −1 ). The ear drops solution (200 µg mL −1 ) of FP was used as a working solution for FP.
Procedure
For TLC-Densitometric Method
Construction of Calibration Curves
Aliquots equivalent to 0.3-4, 0.3-3, and 1.5-5 µg of FP, FL, and CL, respectively, were accurately and separately transferred from their respective working standard solutions (0.1 mg mL −1 ) and applied in triplicates to TLC plates (20 × 10 cm prewashed with methanol and dried at 60°C for 5 min prior to sample application) in the form of bands with a band length of 4 mm. Bands were applied 20 mm apart from each other and 15 mm from the bottom edge. Linear ascending development was performed in a chromatographic tank previously saturated with benzene-hexane-acetone-formic acid (5:4:2:0.13, by volume) for 30 min. The migration distance was 100 mm from the lower edge of the plate, and the developed plates were air dried and scanned at 235 nm under the specified instrumental conditions. Calibration curves relating to the recorded integrated area under peak versus the corresponding concentrations as μg band −1 were then constructed from which the regression equations were computed.
Application to Market Samples
The procedure mentioned under construction of calibration curve was followed on the prepared working solution (0.1 mg mL −1 ) of CL and the eye drops solution (200 µg mL −1 ) of FP, and the concentration of FP and CL has been calculated from the corresponding regression equations.
For HPLC Method
Construction of Calibration Curve
Accurate aliquots of FP, FL, and CL were separately transferred from their respective working standard solutions (0.1 mg mL −1 ) into three separate sets of calibrated measuring flasks to prepare solutions having the concentration ranges of 5-50, 2-35, and 10-70 µg mL −1 of FP, FL, and CL, respectively. Triplicate injections were carried out from each of the prepared solutions; the integrated peak area was used to construct the calibration curve for each component from which its regression equation was constructed. Chromatographic separation was carried out in isocratic mode on an ODS column with a mobile phase consisting of acetonitrile-water (70:30, v/v) delivered at a flow rate 1 mL min −1 . The injection volume was 20 µL with UV scanning at 235 nm at room temperature. The run time was 11 min, and the integrated peak area was used to quantify the studied components.
Application to Market Samples
The procedure mentioned under construction of calibration curve was followed on the prepared working solution (0.1 mg mL −1 ) of CL and the eye drops solution equivalent to 200 µg mL −1 of FP, and the concentration of FP and CL has been calculated from the corresponding regression equations.
Results and Discussion
From literature survey, no reported methods were found for the determination of FP and CL in their binary mixtures or in the presence of FL, the potential impurity, and related substance of FP as stated in the British Pharmacopeia [2] ; therefore, it was necessary to determine the proposed drugs in their binary mixtures and also to determine the lowest concentrations of FL in FP samples. Hence, the present work deals with the development and validation of highly sensitive TLC-densitometric and HPLC methods.
TLC-Densitometric Method
Planar chromatography with precise application of the samples and computer-controlled evaluation and quantitation of the developed chromatograms has been considered reliable for purity control and qualitative drug testing [13] . Also, TLC is one of the useful methods which does not need tedious cleanup, and by using appropriate developing systems, all interfering agents will be omitted [14] .
Method Development and Optimization
For application of the method, the conditions were optimized to get the best resolution and efficiency.
Several trial experiments were performed in order to select a suitable mobile phase for optimum separation of the three components. Several solvent systems were tried, e.g., hexane-acetone (7:3, v/v), benzene-methanol (8:2, v/v), and benzene-hexane-acetone (5:3:2, v/v). Good resolution was obtained from the latter, but the problem was that CL was detected as tailed peak. Formic acid was used to enhance the shape of CL and also to enhance separation.
The saturation time required before development is important to achieve homogeneity of the atmosphere, thus, minimizing the evaporation of the solvent from TLC plate during the development [15] . The saturation time of the developing system has been optimized and found to be 30 min.
Different scanning wavelengths (220, 235 and 254 nm) were tried in order to enhance the sensitivity of the method; scanning at 235 nm gave the best sensitivity for FP and FL and consider-able sensitivity to CL, which is very important for quality control analysis of FP, and also facilitate the determination of FP in the pharmaceutical formulation in which CL is the major component as the ratio of FP to CL is 1: 50.
Upon applying the optimized conditions, the R F values of the separated components were 0.07, 0.31, and 0.64 for FL, FP, and CL, respectively, obtained by use of a developing system containing benzene-hexane-acetone-formic acid (5:4:2:0.13, by volume) (Figure 1) . As can be seen from the densitograms in Figure 1 , the separated peaks are symmetric and well separated.
HPLC Method
A sensitive, selective, and accurate reversed-phase (RP) HPLC method was developed and validated for the separation and determination of the three studied components and was applied successfully for the determination of the studied drugs in their pharmaceutical formulations.
Method Development and Optimization
Some important parameters affecting chromatographic separation have been studied and optimized such as type of organic modifier (methanol and acetonitrile) and its ratio (25-75% of the mobile phase), flow rate (0.8-1.2 mL min −1 ), and scanning wavelength (220, 235, and 254 nm). Trials have shown that using acetonitrile as an organic modifier greatly enhanced the resolution and peak asymmetry. The ratio of acetonitrile in the mobile phase greatly affected the analysis time, and so it was used in the ratio of 70% which gave the best resolution within 11 min. Different scanning wavelengths were tried to obtain maximum sensitivity for all the separated components, as in TLC-densitometric method scanning at 235 nm gave the best sensitivity for FP and FL and considerable sensitivity to CL, which is very important for the quality control analysis of FP and facilitate determination of FP in dosage forms. Also, the effect of mobile phase flow rate was tested and a flow rate of 1 mL min −1 was found to give good resolution within a short analysis time. After method optimization, chromatographic separation of the three components was achieved using an ODS column with acetonitrile-water (70:30, v/v) as the mobile phase at a flow rate 1 mL min −1 and with UV scanning at 235 nm; the R t values of the three components were found to be 2.97, 6.81, and 10.00 min, for FL, FP, and CL, respectively (Figure 2 ).
Method Validation
Method validation was carried out according to International Conference on Harmonization (ICH) guidelines [16] .
Linearity
Under optimum chromatographic conditions, linearity of the developed methods was evaluated by measuring the integrated peak area of different concentrations each of FP, FL, and CL and then plotting the calibration graphs relating the peak area against the corresponding concentration from which the regression equations were constructed and high values of correlation coefficient were obtained. Ranges and regression equation parameters are listed in Table 1 . Moreover, the plots of residuals against the concentration of the three proposed components were prepared. Difference between the obtained values and those esti- mated using a proper calibration curve is small. The residuals were distributed above and below the zero residual line for the three components (Figures 3, 4) .
Accuracy
The accuracy of the proposed methods was evaluated by measurement of recovery. Accurately measured volumes of FP and CL working standard solutions in the low, medium, and high levels of the calibration plot were added to the eye drops solution and analyzed as described under linearity. The experiments were performed in three different analyses. The values were within acceptable limits (98.0%-102.0%) ( Table 2 ).
Precision
It was studied with respect to both repeatability and intermediate precision. Repeatability was calculated by analysis of three different concentrations of pure components in triplicate on the same day as follows:
For TLC-densitometric method, the used concentrations were 0.5, 1, and 3; 0.5, 2, and 2.5; and 2, 3, and 4 μg band −1 , while, for HPLC method, 10, 20, and 40; 5, 20, and 30; and 20, 50, and 60 μg mL −1 were used for determination of FP, FL, and CL, respectively. The experiment was repeated using the same concentrations three times on three consecutive days to determine the intermediate precision. Good results and acceptable % RSD ( Table 1) were obtained.
Specificity
The selectivity of the methods was demonstrated by good separation of the three studied components (Figures 1, 2) . Also, the absence of any peaks at the retention times of the studied drugs and the good results obtained on applying the method to Viotic ® and Otocort ® ear drops prove that there was no interference from excipients; Table 2 .
Limits of Detection and Quantitation (LOD and LOQ) Based on the Calibration Curve
According to ICH recommendations [16] , specific curves were studied using different samples of the three specified components in the detection range, namely, 0.1, 0.2, and 0.3 for FP and FL; and 0.5, 1, and 1.5 for CL, each in six different analyses. LOD = (SD of the response/slope of the calibration curve) × 3.3, while LOQ = (SD of the response/slope of the calibration curve) × 10. Low values of both LOD and LOQ indicated the high sensitivity of the developed methods (Table 1) .
Robustness
The proposed methods were found to be robust; deliberate small changes in the studied chromatographic conditions (e.g., change in acetone amount ± 0.02, formic acid ± 0.02, and saturation time ± 5 min) in case of TLC-densitometric method or (change in the amount of the organic modifier ± 1% and flow rate ± 0.05 mL min −1 ) HPLC method did not lead to a significant change in R F values, R t values, peak area, or symmetry of the peaks.
System Suitability
System suitability tests (SST) ( Table 3 ) confirmed that both chromatographic systems were adequate for the planned analysis. Also, the calculated SST parameters were within the acceptable criteria for good TLC-densitometric and HPLC practice.
Application to Pharmaceutical Formulation
The proposed chromatographic methods were applied for the determination of FP and CL in their pharmaceutical formulations, Viotic ® and Otocort ® ear drops. The results are represented as percentage recovery and are within acceptable limits (90.0%-110.0%) as shown in Table 2 . The acceptable percentage recovery values confirm the suitability of the proposed methods for the routine determination of these components in their pharmaceutical formulations.
Statistical Analysis
Results obtained by the proposed methods for the determination of pure samples of FP and CL were statistically compared to those obtained by the reported HPLC methods [6, 10] . The results showed no significant differences between them (Table 4 ).
Conclusion
The developed chromatographic methods represent fast analytical procedures for the determination of FP and CL in their binary mixtures and in the presence of FL impurity without previous separation. They have the advantage of determination of FL with high sensitivity which is important for the quality control analysis of FP. On the other hand, application of the method to a phar- maceutical preparation showed that excipients do not interfere with the determination of the studied drugs, and hence, it can be used for their determination either in bulk powder or in pharmaceutical formulations. 
